Molecular detection of aminoglycoside-modifying enzyme genes in Acinetobacter baumannii clinical isolates

Heidary, Mohsen and Salimi Chirani, Alireza and Khoshnood, Saeed and Eslami, Gita and Atyabi, Seyyed Mohammad and Nazem, Habibollah and Fazilati, Mohammad and Hashemi, Ali and Soleimani, Saleh (2017) Molecular detection of aminoglycoside-modifying enzyme genes in Acinetobacter baumannii clinical isolates. Acta Microbiologica et Immunologica Hungarica, 64 (2). pp. 143-150. ISSN 1217-8950

Preview

Text 030.63.2016.022.pdf Download (67kB) | Preview

Abstract

Acinetobacter baumannii is a major opportunistic pathogen in healthcare settings worldwide. In Iran, there are only few reports on the prevalence of aminoglycoside resistance genes among A. baumannii isolates. The aim of this study was to investigate the existence of aminoglycoside-modifying enzyme (AME) genes from A. baumannii strains collected at a university teaching hospital in Iran. One hundred A. baumannii strains were collected between 2014 and 2015 from hospitalized patients at Loghman Hakim Hospital, Tehran, Iran. Antimicrobial susceptibility was determined by disk diffusion method according to the Clinical and Laboratory Standards Institute recommendations. The DNA was extracted using a kit obtained from Bioneer Co. (Korea) and was used as a template for polymerase chain reaction. The most active antimicrobial agent against these strains was colistin. The rate of extended-spectrum cephalosporin resistance was 97%. The aadA1, aadB, aac(6′)-Ib, and aac(3)-IIa genes were found in 85%, 77%, 72%, and 68% of A. baumannii isolates, respectively. This study showed a high prevalence rate of AME genes in A. baumannii. This prevalence rate has explained that further aminoglycoside resistance genes may have role in the resistance of clinical isolates of A. baumannii. Therefore, control and treatment of serious infections caused by this opportunistic pathogen should be given more consideration.

Actions (login required)

Edit Item